UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of February, 2013

Commission File Number: 1-32186

 

 

YM BIOSCIENCES INC.

(Translation of registrant’s name into English)

 

 

Suite 400, Building 11

5045 Orbiter Drive

Mississauga, Ontario

Canada L4W 4Y4

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   ¨             Form 40-F   x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)   ¨

 

 

 

DOCUMENTS FILED

See the Exhibit Index hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

YM BIOSCIENCES INC.

By:

 

/s/ Brett A. Pletcher

 

Brett A. Pletcher

President and Secretary

Date: February 21, 2013

EXHIBIT INDEX

 

Exhibit

  

Description

99.1    Early Warning Report, dated February 8, 2013
YM Biosciences (AMEX:YMI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas YM Biosciences.
YM Biosciences (AMEX:YMI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas YM Biosciences.